Skip to content
★ Sign in to follow
Total declarations
9
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (6 ops.)
€476k

Latest filing published 06 Apr 2020 for Kodiak Sciences Inc., €156k.

Filing timeline

BuySale
Hong Liang

Insider track record

Disclosed buys
0
Disclosed sells
6
Signal history

Hong Liang: trading record in brief

Hong Liang discloses dealings in Kodiak Sciences Inc. to SEC (Form 4). Over a trading history stretching from 7 February 2019 to 2 April 2020, the count stands at 9 filings.

The open-market record consists of 6 sales worth €476k, with no purchase. Besides market trades, the filings include 3 option exercises. In 2020 alone, the filings show no purchases and 6 sales.

The latest filing, published on 6 April 2020, reports an open-market sale of €156k in Kodiak Sciences Inc. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to Hong Liang

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations9 total
  • ▼
    SVP, Discovery MedicineExecutivesKodiak Sciences Inc.
    169,360 USD26SEC
    4,000 shares@ US$42.3430.3% of flowCommon StockSEC:0001209191-20-023673:0
  • ▼
    SVP, Discovery MedicineExecutivesKodiak Sciences Inc.
    120,328 USD25SEC
    2,545 shares@ US$47.2821.4% of flowCommon StockSEC:0001209191-20-021727:0
  • ▼
    SVP, Discovery MedicineExecutivesKodiak Sciences Inc.
    53,529 USD24SEC
    1,103 shares@ US$48.539.5% of flowCommon StockSEC:0001209191-20-021727:1
  • ▼
    SVP, Discovery MedicineExecutivesKodiak Sciences Inc.
    17,248 USD23SEC
    352 shares@ US$49.003.1% of flowCommon StockSEC:0001209191-20-021727:2
  • ▼
    SVP, Discovery MedicineExecutivesKodiak Sciences Inc.
    75,991 USD12SEC
    1,954 shares@ US$38.8913.4% of flowCommon StockSEC:0001209191-20-020648:0
  • ▼
    SVP, Discovery MedicineExecutivesKodiak Sciences Inc.
    81,820 USD12SEC
    2,046 shares@ US$39.9914.5% of flowCommon StockSEC:0001209191-20-020648:1
  • ◇
    SVP, Discovery MedicineExecutivesKodiak Sciences Inc.
    30,420 USD11SEC
    29,250 shares@ US$1.044.7% of flowCommon StockSEC:0001209191-19-059119:0
  • ◇
    SVP, Discovery MedicineExecutivesKodiak Sciences Inc.
    13,691 USD11SEC
    12,916 shares@ US$1.062.1% of flowCommon StockSEC:0001209191-19-059119:1
  • ◇
    See RemarksExecutivesKodiak Sciences Inc.
    83,200 USD3SEC
    80,000 shares@ US$1.0412.4% of flowCommon StockSEC:0000899243-19-003022:0

9 of 9 declarations